← Open Payments lookup

HSUAN-LING LIAO: Open Payments

NPI 1548914591 · SAN JOSE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,694 in 80 payments from 15 companies in 2025. Trend: 2023 $1,518 · 2024 $1,467 · 2025 $1,694

Food & beverage: $1,610Education: $84
CompanyPaymentsAmount
ABBVIE INC.28$476
Gilead Sciences, Inc.13$284
Janssen Biotech, Inc.9$227
Ardelyx, Inc.5$112
Celltrion USA Inc.5$98
Takeda Pharmaceuticals U.S.A., Inc.4$92
Braintree Laboratories, Inc.2$69
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$60
Intercept Pharmaceuticals, Inc.2$52
VIVUS LLC2$50

Products named: TREMFYA, RINVOQ, LINZESS, Livdelzi, IBSRELA, VEGZELMA, ENTYVIO, SKYRIZI.

Industry payments across CA — which companies pay providers there.